title: Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment.
authors.affiliation: Nuclear Medicine Department, Cliniche Humanitas Gavazzeni, Via Gavazzeni 21, 24125, Bergamo, Italy. emilio.bombardieri@gavazzeni.it.
authors.forename: Emilio
authors.initials: E
authors.lastname: Bombardieri
authors.affiliation: Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Evangelista
authors.affiliation: Medical Oncology Department, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
authors.forename: G L
authors.initials: GL
authors.lastname: Ceresoli
authors.affiliation: Academic Unit of Medical Oncology, IRCCS AOU San Martino-IST (San Martino University Hospital and National Cancer Research Institute), Genova, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Boccardo
mesh_terms: D006801:Humans; D008297:Male; D009683:Nuclear Medicine / Q000639:trends*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000532:radiotherapy*; D011883:Radium / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D011883:Radium